FTIHX | VGTSX | FTIHX / VGTSX | |
Total Expense Ratio | 0.06 | 0.17 | 35% |
Annual Report Gross Expense Ratio | 0.06 | 0.17 | 35% |
Fund Existence | 9 years | 29 years | - |
Gain YTD | 23.232 | 21.815 | 106% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.5B | 526B | 3% |
Annual Yield % from dividends | 2.35 | 2.65 | 89% |
Returns for 1 year | 18.88 | 16.24 | 116% |
Returns for 3 years | 58.02 | 47.30 | 123% |
Returns for 5 years | 56.74 | 40.72 | 139% |
Returns for 10 years | N/A | 69.71 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 70.99 | 0.72 | +1.03% |
Invesco Biotechnology & Genome ETF | |||
RMOP | 24.40 | 0.19 | +0.78% |
Rockefeller Opportunistic Muncpl Bd ETF | |||
ITAN | 34.16 | 0.18 | +0.53% |
Sparkline Intangible Value ETF | |||
LDUR | 96.04 | 0.04 | +0.04% |
PIMCO Enhanced Low Duration Active ETF | |||
QDVO | 28.54 | -0.11 | -0.38% |
Amplify CWP Growth & Income ETF |